Genmab A (GMAB) Raw Materials (2023 - 2025)

Genmab A's Raw Materials history runs 3 years deep, the most recent figure standing at $6.0 million for Q4 2025.

• Quarterly Raw Materials rose 500.0% year-over-year to $6.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.0 million (up 500.0% YoY) and the FY2025 annual result came in at $6.0 million, up 500.0% from the prior year.
• Raw Materials was $6.0 million for Q4 2025 at Genmab A, up from $1.0 million in the prior quarter.
• Across five years, Raw Materials topped out at $6.0 million in Q4 2025 and bottomed at $1.0 million in Q4 2024.
• A 3-year average of $3.0 million and a median of $2.0 million in 2023 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2024 — Raw Materials plunged 50.0% — and 2025, when it soared 500.0%.
• Genmab A's Raw Materials stood at $2.0 million in 2023, then plunged by 50.0% to $1.0 million in 2024, then surged by 500.0% to $6.0 million in 2025.
• Business Quant data shows GMAB's Raw Materials at $6.0 million in Q4 2025, $1.0 million in Q4 2024, and $2.0 million in Q4 2023.